High-dose ampicillin plus streptomycin for treatment of a patient with severe infection due to multiresistant enterococci

Clinical Infectious Diseases

Volumn 25, Issue 5, 1997, Pages 1269-1270

  Dodge, Rosemary A ^a   Daly, Jennifer S ^a   Davaro, Raul ^a   Glew, Richard H ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLINAFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; EPEREZOLID; GENTAMICIN; LINEZOLID; NOVOBIOCIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ABDOMINAL INFECTION; ADULT; ARTHRALGIA; ARTICLE; BACTEREMIA; BACTERICIDAL ACTIVITY; CASE REPORT; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENTIATION; ENTEROCOCCUS FAECALIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NEPHROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL; SEIZURE; STREPTOCOCCUS INFECTION;

EID: 0030729176     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516977     Document Type: Article

References (10)

1. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-33.
2. Caron F, Pestel M, Kitzis MD, Lemeland JF, Humbert G, Gutmann L. Comparison of different β-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly β-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis 1995;171:106-12.
3. Landman D, Mobarakai NK, Quale JM. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin. Antimicrob Agents Chemother 1993;37:1904-8.
4. Norris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin Infect Dis 1995;20:1137-44.
5. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 3rd ed. NCCLS document M7-A3. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1993.
6. National Committee for Clinical Laboratory Standards. Methods for determining bactericidal activity of antimicrobial agents: tentative guideline. NCCLS document M26-T. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1992.
7. Torres C, Tenorio C, Lantero M, Gastańares M-J, Baquero F. High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium. Antimicrob Agents Chemother 1993;37:2427-31.
8. Ramos MC, Grayson ML, Eliopoulos GM, Bayer AS. Comparison of daptomycin, vancomycin and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci. Antimicrob Agents Chemother 1992;36:1864-9.
9. Mekonen ET, Noskin GA, Hacek DM, Peterson LR. Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium. Microbial Drug Resistance 1995;1:249-253.
10. Foulds G. Pharmacokinetics of sulbactam/ampicillin in humans: a review. Rev Infect Dis 1986;8(suppl 5):S503-11.